We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+20.33%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$600M
AUM Growth
+$79.5M
(+15%)
Cap. Flow
+$21.8M
Cap. Flow
% of AUM
3.64%
Top 10 Holdings %
Top 10 Hldgs %
21.67%
Holding
133
New
15
Increased
59
Reduced
31
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merit Medical Systems
MMSI
|
+$6.18M |
| 2 |
Privia Health
PRVA
|
+$5.98M |
| 3 |
CONMED
CNMD
|
+$5.55M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
+$5.01M |
| 5 |
MoonLake Immunotherapeutics
MLTX
|
+$4.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$12.1M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$11.6M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
+$6.67M |
| 4 |
BLU
BELLUS Health Inc.
BLU
|
+$5.53M |
| 5 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$5.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.97% |
| 2 | Industrials | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
26
DELISTED
Immunogen Inc
IMGN
| $8.24M | 1.37% |
436,447
-564,997
| -56% | -$6.67M |
|
27
Inspire Medical Systems
INSP
$1.47B
| $7.79M | 1.3% |
24,000
-3,500
| -13% | -$1,000K |
|
|
AGTI
28
DELISTED
Agiliti Inc
AGTI
| $7.74M | 1.29% |
469,277
-40,945
| -8% | -$686K |
|
|
ITCI
29
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $7.59M | 1.27% |
119,852
+5,652
| +5% | +$352K |
|
30
Alkermes
ALKS
$8.11B
| $7.58M | 1.26% |
242,173
+11,073
| +5% | +$335K |
|
31
Tenet Healthcare
THC
$22.2B
| $7.45M | 1.24% |
91,500
-10,000
| -10% | -$712K |
|
32
Denali Therapeutics
DNLI
$3.79B
| $7.24M | 1.21% |
245,291
+441
| +0.2% | +$12.4K |
|
33
Arcus Biosciences
RCUS
$3.33B
| $7.2M | 1.2% |
354,490
+60,844
| +21% | +$1.16M |
|
34
Travere Therapeutics
TVTX
$5.17B
| $6.69M | 1.11% |
435,313
+76,700
| +21% | +$1.4M |
|
35
Zentalis Pharmaceuticals
ZNTL
$332M
| $6.6M | 1.1% |
234,000
| – | – |
|
|
AXNX
36
DELISTED
Axonics, Inc. Common Stock
AXNX
| $6.46M | 1.08% |
127,950
+18,000
| +16% | +$958K |
|
|
37
Merit Medical Systems
MMSI
$4.82B
| $6.36M | 1.06% |
+76,000
| New | +$6.18M |
|
38
Merck
MRK
$322B
| $6.35M | 1.06% |
55,000
| – | – |
|
39
Amgen
AMGN
$209B
| $6.28M | 1.05% |
28,269
+6,349
| +29% | +$1.47M |
|
|
GRTX
40
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $6.26M | 1.04% |
2,005,054
-93,511
| -4% | -$278K |
|
|
41
CONMED
CNMD
$1.3B
| $6.18M | 1.03% |
+45,500
| New | +$5.55M |
|
42
Sarepta Therapeutics
SRPT
$1.64B
| $6.01M | 1% |
52,449
+27,739
| +112% | +$3.58M |
|
43
Olema Pharmaceuticals
OLMA
$977M
| $5.85M | 0.98% |
648,353
-347,556
| -35% | -$2.1M |
|
44
Pfizer
PFE
$143B
| $5.77M | 0.96% |
157,400
| – | – |
|
45
Alnylam Pharmaceuticals
ALNY
$38.3B
| $5.67M | 0.94% |
29,826
+3,256
| +12% | +$646K |
|
46
Vera Therapeutics
VERA
$2.33B
| $5.64M | 0.94% |
351,646
-248,654
| -41% | -$2.25M |
|
|
KRTX
47
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $5.58M | 0.93% |
25,732
-1,148
| -4% | -$246K |
|
48
Replimune Group
REPL
$454M
| $5.54M | 0.92% |
238,541
-23,659
| -9% | -$462K |
|
49
Abbott
ABT
$188B
| $5.48M | 0.91% |
50,248
+15,000
| +43% | +$1.6M |
|
50
Vaxcyte
PCVX
$7.65B
| $5.44M | 0.91% |
108,977
+48,977
| +82% | +$2.32M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Sectoral Asset Management held 133 positions worth $600M, up 15% from $520M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Sectoral Asset Management deployed $21.8M of net new capital in Q2 2023, opening 15 new positions and adding to 59 existing holdings. Its largest new stake was Merit Medical Systems: 76,000 shares worth $6.36M.
By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier, followed by Industrials.
On the sell side, the largest reduction was Shockwave Medical, Inc. Common Stock, an estimated $12.1M trimmed.
- Sectoral Asset Management's largest Q2 2023 buy was Merit Medical Systems: 76,000 shares worth $6.36M.
- Sectoral Asset Management added most to Privia Health in Q2 2023, an estimated $5.98M increase.
- Sectoral Asset Management's biggest Q2 2023 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $12.1M.
- Sectoral Asset Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $11.6M.
- Sectoral Asset Management's ten largest holdings make up 22% of its $600M portfolio in Q2 2023.
- Sectoral Asset Management opened 15 new positions and closed 12 in Q2 2023.
- Sectoral Asset Management's portfolio value rose 15% quarter-over-quarter to $600M.
Based on Sectoral Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.